The PRIMO Study: Paricalcitol Capsules Benefits Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease Stage 3/4
Public ClinicalTrials.gov record NCT00497146. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
The PRIMO Study: Paricalcitol Capsules Benefits in Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease Stage 3/4
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To evaluate the effects of paricalcitol capsules on cardiac structure and function over 48 weeks in patients with Stage 3/4 chronic kidney disease (CKD) who had left ventricular hypertrophy (LVH).
Study identification
- NCT ID
- NCT00497146
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 227 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2008 (Type not available)
- Primary completion
- Sep 2010 (Actual)
- Completion
- Mar 2012 (Actual)
- Last update posted
- Mar 12, 2013
2008 – 2012
United States locations
- U.S. sites
- 30
- U.S. states
- 17
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site Reference ID/Investigator# 8062 | Phoenix | Arizona | 85012 | — |
| Site Reference ID/Investigator# 8867 | Tempe | Arizona | 85284 | — |
| Site Reference ID/Investigator# 8864 | San Diego | California | 92123 | — |
| Site Reference ID/Investigator# 7257 | San Dimas | California | 91773 | — |
| Site Reference ID/Investigator# 7727 | Denver | Colorado | 80230 | — |
| Site Reference ID/Investigator# 8861 | Miami | Florida | 33136 | — |
| Site Reference ID/Investigator# 7260 | Orlando | Florida | 32806 | — |
| Site Reference ID/Investigator# 7725 | Tampa | Florida | 33603 | — |
| Site Reference ID/Investigator# 7824 | Tampa | Florida | 33614 | — |
| Site Reference ID/Investigator# 18882 | Meridian | Idaho | 83642 | — |
| Site Reference ID/Investigator# 7823 | Chicago | Illinois | 60617 | — |
| Site Reference ID/Investigator# 7249 | Evergreen Park | Illinois | 60805 | — |
| Site Reference ID/Investigator# 7816 | Bethesda | Maryland | 20814 | — |
| Site Reference ID/Investigator# 18881 | Rockville | Maryland | 20852 | — |
| Site Reference ID/Investigator# 7817 | Springfield | Massachusetts | 01107 | — |
| Site Reference ID/Investigator# 7245 | Detroit | Michigan | 48202 | — |
| Site Reference ID/Investigator# 7248 | Royal Oak | Michigan | 48073 | — |
| Site Reference ID/Investigator# 8868 | Kansas City | Missouri | 64128 | — |
| Site Reference ID/Investigator# 7828 | St Louis | Missouri | 63110 | — |
| Site Reference ID/Investigator# 14442 | Omaha | Nebraska | 68131-3403 | — |
| Site Reference ID/Investigator# 6567 | Winston-Salem | North Carolina | 27103 | — |
| Site Reference ID/Investigator# 7262 | Winston-Salem | North Carolina | 27157-1045 | — |
| Site Reference ID/Investigator# 7826 | Allentown | Pennsylvania | 18103 | — |
| Site Reference ID/Investigator# 8865 | Chattanooga | Tennessee | 37404 | — |
| Site Reference ID/Investigator# 7261 | Houston | Texas | 77004 | — |
| Site Reference ID/Investigator# 8058 | Houston | Texas | 77099 | — |
| Site Reference ID/Investigator# 7830 | San Antonio | Texas | 78229 | — |
| Site Reference ID/Investigator# 7825 | Murray | Utah | 84157-7000 | — |
| Site Reference ID/Investigator# 8866 | Provo | Utah | 84604 | — |
| Site Reference ID/Investigator# 7263 | Fairfax | Virginia | 22033 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 41 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00497146, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 12, 2013 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00497146 live on ClinicalTrials.gov.